Truvestments Capital LLC - TRACON PHARMACEUTICALS INC ownership

TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H209. A total of 22 filers reported holding TRACON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Truvestments Capital LLC ownership history of TRACON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$57
-38.7%
3180.0%0.00%
Q2 2023$93
-84.5%
3180.0%0.00%
Q1 2023$601
+26.8%
3180.0%0.00%
Q4 2022$474
-52.6%
3180.0%0.00%
-100.0%
Q3 2022$1,0000.0%3180.0%0.00%0.0%
Q2 2022$1,0000.0%3180.0%0.00%0.0%
Q4 2021$1,0000.0%3180.0%0.00%0.0%
Q3 2021$1,000
-50.0%
3180.0%0.00%0.0%
Q2 2021$2,000
-33.3%
3180.0%0.00%
-50.0%
Q1 2021$3,0003180.00%
Other shareholders
TRACON PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Opaleye Management Inc. 2,518,371$9,746,0001.82%
Altium Capital Management LP 785,341$3,039,0000.80%
Ikarian Capital, LLC 2,691,110$10,415,0000.73%
Telemetry Investments, L.L.C. 130,500$505,0000.68%
Psagot Value Holdings Ltd. 143,591$556,0000.10%
Psagot Value Holdings Ltd. / (Israel) 143,591$556,0000.10%
ACT CAPITAL MANAGEMENT, LLC 28,500$110,0000.06%
X-Square Capital, LLC 17,973$70,0000.04%
GSA CAPITAL PARTNERS LLP 85,993$333,0000.03%
BOOTHBAY FUND MANAGEMENT, LLC 268,301$1,038,0000.03%
View complete list of TRACON PHARMACEUTICALS INC shareholders